CI Global Investments Inc. purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNH) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 166,294 shares of the healthcare conglomerate’s stock, valued at approximately $30,834,000.

Several other institutional investors and hedge funds have also modified their holdings of the company. Jacobi Capital Management LLC increased its stake in shares of UnitedHealth Group by 6.6% in the 2nd quarter. Jacobi Capital Management LLC now owns 729 shares of the healthcare conglomerate’s stock valued at $136,000 after purchasing an additional 45 shares during the last quarter. Alliancebernstein L.P. increased its stake in shares of UnitedHealth Group by 2.3% in the 2nd quarter. Alliancebernstein L.P. now owns 7,906,936 shares of the healthcare conglomerate’s stock valued at $1,466,104,000 after purchasing an additional 174,290 shares during the last quarter. Pittenger & Anderson Inc. grew its position in UnitedHealth Group by 0.9% during the 2nd quarter. Pittenger & Anderson Inc. now owns 28,796 shares of the healthcare conglomerate’s stock worth $5,339,000 after acquiring an additional 246 shares during the last quarter. Aberdeen Asset Management PLC UK grew its position in UnitedHealth Group by 11.8% during the 2nd quarter. Aberdeen Asset Management PLC UK now owns 791,882 shares of the healthcare conglomerate’s stock worth $146,832,000 after acquiring an additional 83,723 shares during the last quarter. Finally, HPM Partners LLC grew its position in UnitedHealth Group by 7.8% during the 2nd quarter. HPM Partners LLC now owns 41,486 shares of the healthcare conglomerate’s stock worth $7,692,000 after acquiring an additional 3,016 shares during the last quarter. Institutional investors own 86.00% of the company’s stock.

A number of brokerages recently weighed in on UNH. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, November 2nd. Credit Suisse Group began coverage on UnitedHealth Group in a research report on Thursday, November 2nd. They set an “outperform” rating and a $233.00 price objective on the stock. Mizuho restated a “buy” rating on shares of UnitedHealth Group in a research report on Tuesday, October 24th. Oppenheimer Holdings, Inc. boosted their price objective on UnitedHealth Group from $215.00 to $205.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 18th. Finally, Sanford C. Bernstein restated an “outperform” rating and set a $219.00 price objective (up previously from $210.00) on shares of UnitedHealth Group in a research report on Thursday, October 19th. Three equities research analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $216.65.

COPYRIGHT VIOLATION NOTICE: This news story was first posted by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this news story on another site, it was illegally stolen and reposted in violation of United States and international copyright laws. The legal version of this news story can be read at https://theolympiareport.com/2017/11/15/ci-global-investments-inc-purchases-new-position-in-unitedhealth-group-incorporated-unh.html.

Shares of UnitedHealth Group Incorporated (NYSE:UNH) opened at $211.71 on Wednesday. UnitedHealth Group Incorporated has a 12-month low of $148.56 and a 12-month high of $213.93. The company has a market capitalization of $204,541.08, a PE ratio of 21.99, a P/E/G ratio of 1.57 and a beta of 0.64. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, beating analysts’ consensus estimates of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The business had revenue of $50.32 billion during the quarter, compared to analyst estimates of $50.38 billion. During the same period in the previous year, the company posted $2.17 EPS. The firm’s revenue was up 8.7% compared to the same quarter last year. equities analysts anticipate that UnitedHealth Group Incorporated will post 9.99 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Friday, December 1st will be given a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a yield of 1.42%. The ex-dividend date of this dividend is Thursday, November 30th. UnitedHealth Group’s payout ratio is 33.26%.

In related news, insider Thomas E. Roos sold 975 shares of the business’s stock in a transaction dated Thursday, October 19th. The stock was sold at an average price of $205.47, for a total value of $200,333.25. Following the completion of the sale, the insider now directly owns 24,630 shares of the company’s stock, valued at approximately $5,060,726.10. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Richard T. Burke sold 15,000 shares of the business’s stock in a transaction dated Monday, August 21st. The shares were sold at an average price of $191.71, for a total value of $2,875,650.00. Following the completion of the sale, the director now directly owns 1,818,898 shares of the company’s stock, valued at $348,700,935.58. The disclosure for this sale can be found here. Insiders sold a total of 72,149 shares of company stock valued at $14,212,342 over the last ninety days. 0.89% of the stock is currently owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.